公开(公告)号：EP2964635B1

公开(公告)日：2018-05-02

申请号：EP14708234.1

申请日：2014-03-03

申请人： F. Hoffmann-La Roche AG

发明人： BILOTTA, Joseph, Anthony ,  CHEN, Zhi ,  CHI, Feng ,  CHIN, Elbert ,  DING, Qingjie ,  ERICKSON, Shawn, David ,  GABRIEL, Stephen, Deems ,  JIANG, Nan ,  KOCER, Buelent ,  MERTZ, Eric ,  PLANCHER, Jean-Marc ,  WEIKERT, Robert, J. ,  ZHANG, Jing ,  ZHANG, Qiang

IPC分类号： C07D403/12 ,  C07D401/12 ,  C07D405/12 ,  C07D411/12 ,  C07D413/12 ,  C07D417/12 ,  C07D249/14 ,  C07D491/107 ,  C07D495/04 ,  A61K31/4196 ,  A61K31/454 ,  A61K31/425 ,  A61K31/496 ,  A61K31/5377 ,  A61K31/538

CPC分类号： A61K31/4196 ,  A61K31/428 ,  A61K31/454 ,  A61K31/496 ,  A61K31/5377 ,  A61K31/538 ,  A61K31/541 ,  A61K31/5415 ,  A61K45/06 ,  C07D249/14 ,  C07D401/12 ,  C07D403/12 ,  C07D405/12 ,  C07D411/12 ,  C07D413/12 ,  C07D417/12 ,  C07D491/107 ,  C07D495/04

摘要： The present invention discloses compounds of Formula I: wherein the variables in Formula I are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formula I in the prevention or treatment of HCV infection.